维普中文期刊产品整合服务
16篇 您的检索式:作者名="Gooden MJ"
    题名 作者 年代 出处 被引量
1The prognostic influence of tumour-infiltrating lymphocytes in cancer:a systematic review with meta-analysis显示文摘Gooden MJ De Bock GH Leffers N 2011Br J Cancer2011,105,1:1
2Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer显示文摘Leffers N Gooden MJ de Jong RA 2009Cancer Immunol Immunother2009,58,3:1
3Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer显示文摘Leffers N Gooden MJ de Jong RA 2009Cancer Immunol Immunother2009,58,3:1
4Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer显示文摘Leffers N Gooden MJ de Jong RA 2009Cancer Immunol Immunother2009,58,3:1
5Infiltrating CTLs are bothered by HLA-E on tumors显示文摘Gooden MJ van Hall T 2012Oncoimmunology2012,1,1:1
6Prognostic significance oftumor--infiltrating T-lymphocytes in primary and metastatic le- sions of advanced stage ovarian cancer显示文摘Leffers N Gooden MJ deJong RA 2009Cancer Immunol Immu- nother2009,58,3:1
7Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients,a phase Ⅱ trial显示文摘Leffers N Lambeck AJ Gooden MJ 2009Int J Cancer2009,125,9:1
8Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients,a phase Ⅱ trial显示文摘Leffers N Lambeck AJ Gooden MJ 0,,09:1
9Targeted delivery of CD40L promotes restricted activation of antigen-presenting cells and induction of cancer cell death显示文摘Brunekreeft KL Strohm C Gooden MJ 2014Mol Cancer2014,13,:1
10Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a phase Ⅱ trial 显示文摘Leffers N Lambeck A J Gooden MJ 2009Int J Cancer2009,125,9:1
11Hospitalised patients′ views on doctors and white coats显示文摘Gooden BR Smith MJ Tattersall SJ 2001Med J Aust2001,175,4:1
12Immunizationwith a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients,aphaseⅡtrial显示文摘Leffers N Lambeck AJ Gooden MJ 2009Int J Cancer2009,125,9:1
13Elevated serum CXCL16 is an Independent predictor of poor survival in ovarian cancer and May reflect pro-metastatic Adam protease activity显示文摘Gooden MJ Wiersma VR Boerma A 2014British Journal of Cancer2014,110,6:1
14The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis显示文摘Gooden MJ de Bock GH Leffers N Br J Cancer0,105,:1
15Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer显示文摘Leffers N Gooden MJ de Jong RA 2009Cancer Immunol Immunother2009,58,3:1
16Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients,a phase Ⅱ trial显示文摘Leffers N Lambeck AJ Gooden MJ 2009Int J Cancer2009,125,9:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费